In agreement with previous results, showing that deletion of A20 in myeloid cells also protects from Influenza [21], these data suggest that inhibiting A20 expression, for example by local administration of interfering RNAs, might be promising as a new therapeutic strategy to control disease caused by influenza A virus infection. Here, TNFAIP3 is linked to influenza.